HLB Genex Executives Purchase Shares Amid Stock Decline
HLB Genex Chairman Jin Yang-gon and CEO Kim Do-yeon purchased company shares on days 20-21 and day 13 respectively, following a stock price decline triggered by the parent company HLB's liver cancer drug approval delay in the United States. Jin acquired 50,428 shares over two days while Kim purchase
HLB5.96%
LucasBennett·07-22 03:56









